CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment

por Lecoq, Inés, Kopp, Katharina L., Chapellier, Marion, Mantas, Panagiotis, Martinenaite, Evelina, Perez-Penco, Maria, Rønn Olsen, Lars, Zocca, Mai-Britt, Wakatsuki Pedersen, Ayako, Andersen, Mads Hald
Publicado 2022

Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma

por Lauenborg, Britt, Christensen, Louise, Ralfkiaer, Ulrik, Kopp, Katharina L., Jønson, Lars, Dabelsteen, Sally, Bonefeld, Charlotte M., Geisler, Carsten, Gjerdrum, Lise Mette R., Zhang, Qian, Wasik, Mariusz A., Ralfkiaer, Elisabeth, Ødum, Niels, Woetmann, Anders
Publicado 2015

Peptide vaccination directed against IDO1-expressing immune cells elicits CD8(+) and CD4(+) T-cell-mediated antitumor immunity and enhanced anti-PD1 responses

por Dey, Souvik, Sutanto-Ward, Erika, Kopp, Katharina L, DuHadaway, James, Mondal, Arpita, Ghaban, Dema, Lecoq, Inés, Zocca, Mai-Britt, Merlo, Lauren M F, Mandik-Nayak, Laura, Andersen, Mads Hald, Pedersen, Ayako Wakatsuki, Muller, Alexander J
Publicado 2020

Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma

por Sibbesen, Nina A., Kopp, Katharina L., Litvinov, Ivan V., Jønson, Lars, Willerslev-Olsen, Andreas, Fredholm, Simon, Petersen, David L., Nastasi, Claudia, Krejsgaard, Thorbjørn, Lindahl, Lise M., Gniadecki, Robert, Mongan, Nigel P., Sasseville, Denis, Wasik, Mariusz A., Iversen, Lars, Bonefeld, Charlotte M., Geisler, Carsten, Woetmann, Anders, Odum, Niels
Publicado 2015